메뉴 건너뛰기




Volumn 26, Issue 11, 2005, Pages 957-963

High pre-therapy [ 99m tc]pertechnetate thyroid uptake, thyroid size and thyrostatic drugs: predictive factors of failure in [i]iodide therapy in graves' disease

Author keywords

Autoimmune hyperthyroidism; Graves' disease; Radioiodine therapy

Indexed keywords

ANTITHYROID AGENT; IODINE 131; PERTECHNETIC ACID TC 99M; PREDNISONE; PROPYLTHIOURACIL; THIAMAZOLE; THIONAMIDE; THYROID ANTIBODY; THYROTROPIN; THYROXINE;

EID: 27344437672     PISSN: 01433636     EISSN: 14735628     Source Type: Journal    
DOI: 10.1097/01.mnm.0000183795.59097.42     Document Type: Article
Times cited : (46)

References (38)
  • 1
    • 0003846882 scopus 로고    scopus 로고
    • Werner and Ingbar. The Thyroid
    • Introduction to thyrotoxicosis, Lewis E, Braverman, R. Utiger, Philadelphia, Lippincott-Raven
    • Braverman LE, Utiger RD. Introduction to thyrotoxicosis. In: Lewis E, Braverman, R. Utiger (editors): Werner and Ingbar. The Thyroid. Philadelphia: Lippincott-Raven; 1996, p. 522.
    • (1996) , pp. 522
    • Braverman, L.E.1    Utiger, R.D.2
  • 2
    • 0025851976 scopus 로고
    • High incidence of multinodular toxic goitre in the elderly population in a low iodine intake area vs. high incidence of Graves' disease in the young in a high iodine area: comparative surveys of thyrotoxicosis epidemiology in East Jutland, Denmark, and Iceland
    • Lauberg P, Pedersen KM, Vestergaard H, Sigurdsson G. High incidence of multinodular toxic goitre in the elderly population in a low iodine intake area vs. high incidence of Graves' disease in the young in a high iodine area: comparative surveys of thyrotoxicosis epidemiology in East Jutland, Denmark, and Iceland. J Int Med 1991; 229:415-420.
    • (1991) J Int Med , vol.229 , pp. 415-420
    • Lauberg, P.1    Pedersen, K.M.2    Vestergaard, H.3    Sigurdsson, G.4
  • 3
    • 0026295126 scopus 로고
    • Difference and similarities in diagnosis and treatment of Graves' disease in Europe, Japan and United States
    • Wartofsky L, Glinoer D, Solomon B, Nagataki S, Lagasse R, Nagayama Y, Izumi M. Difference and similarities in diagnosis and treatment of Graves' disease in Europe, Japan and United States. Thyroid 1991; 1:129-135.
    • (1991) Thyroid , vol.1 , pp. 129-135
    • Wartofsky, L.1    Glinoer, D.2    Solomon, B.3    Nagataki, S.4    Lagasse, R.5    Nagayama, Y.6    Izumi, M.7
  • 4
    • 0024382368 scopus 로고
    • Prospective multicentre study on prediction of relapse after antithyroid drug treatment in patients with Graves' disease
    • Schleusener H, Schwander J, Fischer C, Holle R, Holl G, Badenhoop K, et al. Prospective multicentre study on prediction of relapse after antithyroid drug treatment in patients with Graves' disease. Acta Endocrinol 1989; 120:689-701.
    • (1989) Acta Endocrinol , vol.120 , pp. 689-701
    • Schleusener, H.1    Schwander, J.2    Fischer, C.3    Holle, R.4    Holl, G.5    Badenhoop, K.6
  • 5
    • 0030829438 scopus 로고    scopus 로고
    • Clinical features of patients with Graves' disease undergoing remission after antithyroid drug treatment
    • Vitti P, Rago T, Chiovato L, Pallini S, Santini F, Fiore E, et al. Clinical features of patients with Graves' disease undergoing remission after antithyroid drug treatment. Thyroid 1997; 7:369-375.
    • (1997) Thyroid , vol.7 , pp. 369-375
    • Vitti, P.1    Rago, T.2    Chiovato, L.3    Pallini, S.4    Santini, F.5    Fiore, E.6
  • 7
    • 0037364219 scopus 로고    scopus 로고
    • How should the dose of iodine-131 be determined in the treatment of Graves' hyperthyroidism?
    • Kalinyak JE, Mc Dougall IR. How should the dose of iodine-131 be determined in the treatment of Graves' hyperthyroidism? J Clin Endocrinol Metab 2003; 88:3975-3977.
    • (2003) J Clin Endocrinol Metab , vol.88 , pp. 3975-3977
    • Kalinyak, J.E.1    Mc Dougall, I.R.2
  • 15
    • 0036962179 scopus 로고    scopus 로고
    • 131 I therapy for the treatment of hyperthyroidism caused by Graves' disease
    • 131 I therapy for the treatment of hyperthyroidism caused by Graves' disease. J Clin Endocrinol Metab 2002; 87:1073-1077.
    • (2002) J Clin Endocrinol Metab , vol.87 , pp. 1073-1077
    • Alexander, E.K.1    Larsen, P.R.2
  • 16
    • 0029815149 scopus 로고    scopus 로고
    • Changes in thyroid volume in response to radioactive iodine for Graves' hyperthyroidism correlated with activity of thyroid-stimulating antibody and treatment outcome
    • Murakami Y, Takamatsu J, Sakane S, Kuma K, Ohsawa N. Changes in thyroid volume in response to radioactive iodine for Graves' hyperthyroidism correlated with activity of thyroid-stimulating antibody and treatment outcome. J Clin Endocrinol Metab 1996; 81:3257-3260.
    • (1996) J Clin Endocrinol Metab , vol.81 , pp. 3257-3260
    • Murakami, Y.1    Takamatsu, J.2    Sakane, S.3    Kuma, K.4    Ohsawa, N.5
  • 17
    • 2442691356 scopus 로고    scopus 로고
    • Onset age is associated with outcome of radioiodine therapy in Graves' disease
    • Yamashita Y, Yamane K, Tamura T, Okubo M, Kohno N. Onset age is associated with outcome of radioiodine therapy in Graves' disease. Endocr J 2004; 51:127-132.
    • (2004) Endocr J , vol.51 , pp. 127-132
    • Yamashita, Y.1    Yamane, K.2    Tamura, T.3    Okubo, M.4    Kohno, N.5
  • 19
    • 0029156393 scopus 로고
    • Treatment with propylthiouracil before radioactive iodine therapy is associated with a higher treatment failure rate than therapy with radioactive iodine alone in Graves' disease
    • Tuttle RM, Patience T, Budd S. Treatment with propylthiouracil before radioactive iodine therapy is associated with a higher treatment failure rate than therapy with radioactive iodine alone in Graves' disease. Thyroid 1995; 5:243-247.
    • (1995) Thyroid , vol.5 , pp. 243-247
    • Tuttle, R.M.1    Patience, T.2    Budd, S.3
  • 20
    • 0031792515 scopus 로고    scopus 로고
    • Pretreatment with propylthiouracil but not methimazole reduces the therapeutic efficacy of iodine-131 in hyperthyroidism
    • Imseis RE, Vanmiddlesworth L, Massie JD, Bush AJ, Vanmiddlesworth NR. Pretreatment with propylthiouracil but not methimazole reduces the therapeutic efficacy of iodine-131 in hyperthyroidism. J Clin Endocrinol Metab 1998; 83:685-687.
    • (1998) J Clin Endocrinol Metab , vol.83 , pp. 685-687
    • Imseis, R.E.1    Vanmiddlesworth, L.2    Massie, J.D.3    Bush, A.J.4    Vanmiddlesworth, N.R.5
  • 23
    • 0036195724 scopus 로고    scopus 로고
    • The effect of methimazole on cure rates after radioiodine treatment for Graves' hyperthyroidism: a randomized clinical trial
    • Braga M, Walpert N, Burch HB, Solomon BL, Copper DS. The effect of methimazole on cure rates after radioiodine treatment for Graves' hyperthyroidism: a randomized clinical trial. Thyroid 2002; 12:135-139.
    • (2002) Thyroid , vol.12 , pp. 135-139
    • Braga, M.1    Walpert, N.2    Burch, H.B.3    Solomon, B.L.4    Copper, D.S.5
  • 24
    • 0018354172 scopus 로고
    • 99m Tc-pertechnetate thyroid uptake ratio and neck/thigh ratio
    • 99m Tc-pertechnetate thyroid uptake ratio and neck/thigh ratio. Am J Roentgenol 1979; 132:249-253.
    • (1979) Am J Roentgenol , vol.132 , pp. 249-253
    • Schneider, P.B.1
  • 25
  • 26
    • 33744880855 scopus 로고
    • Statistical Methods for Rates and Proportions. 2nd edition
    • New York, John Wiley
    • Fleiss JL. Statistical Methods for Rates and Proportions. 2nd edition. New York: John Wiley; 1981.
    • (1981)
    • Fleiss, J.L.1
  • 27
    • 0003508724 scopus 로고
    • Applied Logistic Regression
    • New York, John Wiley
    • Hosmer DW, Lemeshow S. Applied Logistic Regression. New York: John Wiley; 1989.
    • (1989)
    • Hosmer, D.W.1    Lemeshow, S.2
  • 28
    • 85026153078 scopus 로고    scopus 로고
    • Hamilton JG, Lawrence JH. Recent clinical developments in the therapeutic application of radiophosphorus and radio-iodine. J Clin Invest 1942; 21:624 (Abstract).
    • Hamilton JG, Lawrence JH. Recent clinical developments in the therapeutic application of radiophosphorus and radio-iodine. J Clin Invest 1942; 21:624 (Abstract).
  • 29
    • 85026154129 scopus 로고    scopus 로고
    • Hertz S, Roberts A. Application of radioactive iodine in the therapy of Graves' disease. J Clin Invest 1942; 21:624 (Abstract).
    • Hertz S, Roberts A. Application of radioactive iodine in the therapy of Graves' disease. J Clin Invest 1942; 21:624 (Abstract).
  • 30
    • 0028775261 scopus 로고
    • The management of hyperthyroidism
    • Franklin JA. The management of hyperthyroidism. N Engl J Med 1994; 330:1731-1738.
    • (1994) N Engl J Med , vol.330 , pp. 1731-1738
    • Franklin, J.A.1
  • 33
    • 0036361004 scopus 로고    scopus 로고
    • Radioiodine therapy and thyrostatic drugs and iodine
    • Moka D, Dietlein M, Schicha H. Radioiodine therapy and thyrostatic drugs and iodine. Eur J Nucl Med 2002; 29(suppl 2):486-491.
    • (2002) Eur J Nucl Med , vol.29 , pp. 486-491
    • Moka, D.1    Dietlein, M.2    Schicha, H.3
  • 34
    • 85026154485 scopus 로고    scopus 로고
    • DeGroot LJ. Graves' disease and the manifestations of thyrotoxicosis. , 2003.
    • DeGroot LJ. Graves' disease and the manifestations of thyrotoxicosis. , 2003.
  • 35
    • 0020041414 scopus 로고
    • Preferential inhibition of thyroxine and 3,5,3′-triiodothyronine formation by propylthiouracil and methylmercaptoimidazole in thyroid peroxidase-catalyzed iodination of thyroglobulin
    • Engler H, Taurog A, Dorris ML. Preferential inhibition of thyroxine and 3,5,3′-triiodothyronine formation by propylthiouracil and methylmercaptoimidazole in thyroid peroxidase-catalyzed iodination of thyroglobulin. Endocrinology 1982; 110:190-197.
    • (1982) Endocrinology , vol.110 , pp. 190-197
    • Engler, H.1    Taurog, A.2    Dorris, M.L.3
  • 36
    • 0024476755 scopus 로고
    • 14 C- labeled 1-methyl-2-mercaptoimidazole in vitro and in vivo
    • 14 C- labeled 1-methyl-2-mercaptoimidazole in vitro and in vivo. Endocrinology 1989; 124:3030-3037.
    • (1989) Endocrinology , vol.124 , pp. 3030-3037
    • Taurog, A.1    Dorris, M.L.2    Guziec, F.S.3
  • 37
    • 0024349734 scopus 로고
    • A reexamination of the proposed inactivation of thyroid peroxidase in the rat thyroid by propylthiouracil
    • Taurog A, Dorris ML. A reexamination of the proposed inactivation of thyroid peroxidase in the rat thyroid by propylthiouracil. Endocrinology 1989; 124:3038-3042.
    • (1989) Endocrinology , vol.124 , pp. 3038-3042
    • Taurog, A.1    Dorris, M.L.2
  • 38
    • 0027475621 scopus 로고
    • Influence of dose selection on absorbed dose profiles in radioiodine treatment of diffuse toxic goiters in patients receiving or not receiving carbimazole
    • Clerc J, Izembart M, Dagousset F, Jais JP, Heshmati HM, Chevalier A, et al. Influence of dose selection on absorbed dose profiles in radioiodine treatment of diffuse toxic goiters in patients receiving or not receiving carbimazole. J Nucl Med 1993; 34:387-389.
    • (1993) J Nucl Med , vol.34 , pp. 387-389
    • Clerc, J.1    Izembart, M.2    Dagousset, F.3    Jais, J.P.4    Heshmati, H.M.5    Chevalier, A.6


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.